Investigation of parent-of-origin effects induced by fenofibrate treatment on triglycerides levels

BMC Genet. 2018 Sep 17;19(Suppl 1):83. doi: 10.1186/s12863-018-0640-9.

Abstract

Background: Genome-wide association studies performed on triglycerides (TGs) have not accounted for epigenetic mechanisms that may partially explain trait heritability.

Results: Parent-of-origin (POO) effect association analyses using an agnostic approach or a candidate approach were performed for pretreatment TG levels, posttreatment TG levels, and pre- and posttreatment TG-level differences in the real GAW20 family data set. We detected 22 genetic variants with suggestive POO effects with at least 1 phenotype (P ≤ 10- 5). We evaluated the association of these 22 significant genetic variants showing POO effects with close DNA methylation probes associated with TGs. A total of 18 DNA methylation probes located in the vicinity of the 22 SNPs were associated with at least 1 phenotype and 6 SNP-probe pairs were associated with DNA methylation probes at the nominal level of P < 0.05, among which 1 pair presented evidence of POO effect. Our analyses identified a paternal effect of SNP rs301621 on the difference between pre- and posttreatment TG levels (P = 1.2 × 10- 5). This same SNP showed evidence for a maternal effect on methylation levels of a nearby probe (cg10206250; P = 0.01). Using a causal inference test we established that the observed POO effect of rs301621 was not mediated by DNA methylation at cg10206250.

Conclusions: We performed POO effect association analyses of SNPs with TGs, as well as association analyses of SNPs with DNA methylation probes. These analyses, which were followed by a causal inference test, established that the paternal effect at the SNP rs301621 is induced by treatment and is not mediated by methylation level at cg10206250.

Keywords: DNA methylation; Epigenetics; Fenofibrate treatment; Parent-of-origin effects; Triglycerides.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • CpG Islands
  • DNA Methylation
  • Epigenomics
  • Fenofibrate / therapeutic use*
  • Genome-Wide Association Study
  • Humans
  • Hypertriglyceridemia / drug therapy*
  • Hypertriglyceridemia / genetics
  • Hypoglycemic Agents / therapeutic use*
  • Parents
  • Phenotype
  • Polymorphism, Single Nucleotide
  • Triglycerides / blood*

Substances

  • Hypoglycemic Agents
  • Triglycerides
  • Fenofibrate